Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cellebrite DI Ltd (NASDAQ: CLBT) was $18.16 for the day, up 0.39% from the previous closing price of $18.09. In other words, the price has increased by $0.39 from its previous closing price. On the day, 0.8 million shares were traded. CLBT stock price reached its highest trading level at $18.45 during the session, while it also had its lowest trading level at $17.9408.
Ratios:
Our analysis of CLBT’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 15 ’24 when YOSEF CARMIL bought 157,987 shares for $18.06 per share.
YOSEF CARMIL bought 100,000 shares of CLBT for $1,751,000 on Sep 16 ’24. On Sep 04 ’24, another insider, Ben-Peretz Leeor, who serves as the Officer of the company, bought 8,919 shares for $16.95 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 3901549056 and an Enterprise Value of 3474924544. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.42. Its current Enterprise Value per Revenue stands at 9.586 whereas that against EBITDA is 57.004.
Stock Price History:
Over the past 52 weeks, CLBT has reached a high of $18.73, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 9.17%, while the 200-Day Moving Average is calculated to be 46.03%.
Shares Statistics:
CLBT traded an average of 1.39M shares per day over the past three months and 1364290 shares per day over the past ten days. A total of 203.23M shares are outstanding, with a floating share count of 61.62M. Insiders hold about 70.39% of the company’s shares, while institutions hold 33.51% stake in the company. Shares short for CLBT as of 1727654400 were 1347824 with a Short Ratio of 0.97, compared to 1724976000 on 3897981. Therefore, it implies a Short% of Shares Outstanding of 1347824 and a Short% of Float of 1.21.
